Nevus of Ota

Last updated
Nevus of Ota
Other namesCongenital melanosis bulbi, [1] nevus fuscoceruleus ophthalmomaxillaris, oculodermal melanocytosis, [2] :700 oculomucodermal melanocytosis [1]
Naveus of ota.jpg
Specialty Oncology   OOjs UI icon edit-ltr-progressive.svg

Nevus of Ota is a hyperpigmentation [3] that occurs on the face, most often appearing on the white of the eye. It also occurs on the forehead, nose, cheek, periorbital region, and temple. [4]

Contents

It was first reported by Masao Ōta of Japan in 1939. [5]

Cause

Nevus of Ota is caused by the entrapment of melanocytes in the upper third of the dermis. It is found only on the face, most commonly unilaterally, rarely bilaterally and involves the first two branches of the trigeminal nerve. The sclera is involved in two-thirds of cases (causing an increased risk of glaucoma). It should not be confused with Mongolian spot, which is a birthmark caused by entrapment of melanocytes in the dermis but is located in the lumbosacral region. Women are nearly five times more likely to be affected than men, and it is rare among Caucasian people. [6] Nevus of Ota may not be congenital, and may appear during puberty.

Skin treatment

A Q-switched 1064 nm laser has been successfully used to treat the condition. [7] [8] The Q-switched lasers (694 nm ruby, 755 nm Alexandrite or 1064 nm Nd-YAG) with their high peak power and pulse width in nano second range are best suited to treat various epidermal, junctional, mixed and dermal lesions. The Q-switched 1064 nm Nd-YAG is an ideal choice to treat dermal pigment as in nevus of Ota and in darker skin types, as it reduces the risk of epidermal injury and pigmentary alterations. The pigment clearance can be expected to be near total, using multiple treatment sessions, each separated by a minimum of six weeks. The number of treatments required depends on the severity of the lesion. A darker lesion needs more treatments. The outcome also depends to some extent on the power output and quality of the laser system. Last but not least, the skill of the laser surgeon plays a role in achieving early and good clearance. [9]

Treatment

A specific form of conjunctivoplasty may help somewhat.[ citation needed ]

Notable cases

See also

Related Research Articles

<span class="mw-page-title-main">Melanocytic nevus</span> Skin condition, mole

A melanocytic nevus is usually a noncancerous condition of pigment-producing skin cells. It is a type of melanocytic tumor that contains nevus cells. Some sources equate the term mole with "melanocytic nevus", but there are also sources that equate the term mole with any nevus form.

<span class="mw-page-title-main">Birthmark</span> Medical condition

A birthmark is a congenital, benign irregularity on the skin which is present at birth or appears shortly after birth—usually in the first month. Birthmarks can occur anywhere on the skin. They are caused by overgrowth of blood vessels, melanocytes, smooth muscle, fat, fibroblasts, or keratinocytes.

<span class="mw-page-title-main">Mongolian spot</span> Type of birthmark

A Mongolian spot, also known as slate grey nevus or congenital dermal melanocytosis, is a benign, flat, congenital birthmark with wavy borders and an irregular shape. In 1883, it was described and named after Mongolians by Erwin Bälz, a German anthropologist based in Japan, who erroneously believed it to be most prevalent among his Mongolian patients. It normally disappears three to five years after birth and almost always by puberty. The most common color is blue, although they can be blue-gray, blue-black or deep brown.

<span class="mw-page-title-main">Nevus</span> Mole or birthmark; visible, circumscribed, chronic skin lesion

Nevus is a nonspecific medical term for a visible, circumscribed, chronic lesion of the skin or mucosa. The term originates from nævus, which is Latin for "birthmark"; however, a nevus can be either congenital or acquired. Common terms, including mole, birthmark, and beauty mark, are used to describe nevi, but these terms do not distinguish specific types of nevi from one another.

<span class="mw-page-title-main">Melasma</span> Medical condition

Melasma is a tan or dark skin discoloration. Melasma is thought to be caused by sun exposure, genetic predisposition, hormone changes, and skin irritation. Although it can affect anyone, it is particularly common in women, especially pregnant women and those who are taking oral or patch contraceptives or hormone replacement therapy medications.

<span class="mw-page-title-main">Lentigo maligna</span> Medical condition

Lentigo maligna is where melanocyte cells have become malignant and grow continuously along the stratum basale of the skin, but have not invaded below the epidermis. Lentigo maligna is not the same as lentigo maligna melanoma, as detailed below. It typically progresses very slowly and can remain in a non-invasive form for years.

<span class="mw-page-title-main">Congenital melanocytic nevus</span> Congenital mole caused by genetic mutations

The congenital melanocytic nevus is a type of melanocytic nevus found in infants at birth. This type of birthmark occurs in an estimated 1% of infants worldwide; it is located in the area of the head and neck 15% of the time.

<span class="mw-page-title-main">Becker's nevus</span> Medical condition

Becker's nevus is a benign skin disorder predominantly affecting males. The nevus can be present at birth, but more often shows up around puberty. It generally first appears as an irregular pigmentation on the torso or upper arm, and gradually enlarges irregularly, becoming thickened and often hairy (hypertrichosis). The nevus is due to an overgrowth of the epidermis, pigment cells (melanocytes), and hair follicles. This form of nevus was first documented in 1948 by American dermatologist Samuel William Becker (1894–1964).

<span class="mw-page-title-main">Tattoo removal</span> Dermatologic procedure to remove tattoo pigments

Tattoo removal is the process of removing an unwanted tattoo. The process of tattooing generally creates permanent markings in the skin, but people have attempted many methods to try to hide or destroy tattoos.

<span class="mw-page-title-main">Blue nevus</span> Type of melanocytic tumor

A blue nevus is a type of coloured mole, typically a single well-defined blue-black bump.

<span class="mw-page-title-main">Skin biopsy</span> Removal of skin cells for medical examination

Skin biopsy is a biopsy technique in which a skin lesion is removed to be sent to a pathologist to render a microscopic diagnosis. It is usually done under local anesthetic in a physician's office, and results are often available in 4 to 10 days. It is commonly performed by dermatologists. Skin biopsies are also done by family physicians, internists, surgeons, and other specialties. However, performed incorrectly, and without appropriate clinical information, a pathologist's interpretation of a skin biopsy can be severely limited, and therefore doctors and patients may forgo traditional biopsy techniques and instead choose Mohs surgery.

Roy G. Geronemus is an American dermatologist in the field of laser treatment of skin disorders.

<span class="mw-page-title-main">Halo nevus</span> Medical condition

Halo nevus is a mole that is surrounded by a depigmented ring or 'halo'.

<span class="mw-page-title-main">Benign melanocytic nevus</span> Medical condition

A benign melanocytic nevus is a cutaneous condition characterised by well-circumscribed, pigmented, round or ovoid lesions, generally measuring from 2 to 6 mm in diameter. A benign melanocytic nevus may feature hair or pigmentation as well.

Pseudomelanoma is a cutaneous condition in which melanotic skin lesions clinically resemble a superficial spreading melanoma at the site of a recent shave removal of a melanocytic nevus.

Postinflammatory hypopigmentation is a cutaneous condition characterized by decreased pigment in the skin following inflammation of the skin.

Oral pigmentation is asymptomatic and does not usually cause any alteration to the texture or thickness of the affected area. The colour can be uniform or speckled and can appear solitary or as multiple lesions. Depending on the site, depth, and quantity of pigment, the appearance can vary considerably.

<span class="mw-page-title-main">Nevus depigmentosus</span> Medical condition

Nevus depigmentosus is a loss of pigment in the skin which can be easily differentiated from vitiligo. Although age factor has not much involvement in the nevus depigmentosus but in about 19% of the cases these are noted at birth. Their size may however grow in proportion to growth of the body. The distribution is also fairly stable and are nonprogressive hypopigmented patches. The exact cause of nevus depigmentosus is still not clearly understood. A sporadic defect in the embryonic development has been suggested to be a causative factor. It has been described as "localised albinism", though this is incorrect.

<span class="mw-page-title-main">Supernumerary nipples–uropathies–Becker's nevus syndrome</span> Medical condition

Supernumerary nipples–uropathies–Becker's nevus syndrome is a skin condition that may be associated with genitourinary tract abnormalities. Supernumerary nipples, also referred to as polythelia or accessory nipples, is a pigmented lesion of the skin that is present at birth. This pigmentation usually occurs along the milk lines, which are the precursors to breast and nipple development. Clinically, this congenital condition is generally considered benign, but some studies have suggested there may be an association with kidney diseases and cancers of the urogenital system.

Mucinous nevus is a rare cutaneous condition characterized by hamartoma that can be congenital or acquired. Mucinous nevus presents as multiple skin-coloured or brown asymptomatic papules or plaques. Mucinous nevus is diagnosed based of histological features. Treatment is not needed.

References

  1. 1 2 Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph (2007). Dermatology: 2-Volume Set. St. Louis, Missouri: Mosby. pp. 1720–22. ISBN   978-1-4160-2999-1.
  2. James, William D.; Berger, Timothy G. (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Philadelphia, Pennsylvania: Saunders Elsevier. ISBN   0-7216-2921-0.
  3. Chan, Henry H.L.; Kono, Taro (March–April 2003). "Nevus of Ota: clinical aspects and management". Skinmed. 2 (2). Hoboken, New Jersey: Wiley: 89–96. doi:10.1111/j.1540-9740.2003.01706.x. PMID   14673306 via Medscape.
  4. Mohan, Ravi Prakash Sasankoti; Verma, Sankalp; Singh, Amit Kumar; Singh, Udita (March 2013). "'Nevi of Ota: the unusual birthmarks': a case review". BMJ Case Reports. 2013. London, England: British Medical Association: bcr2013008648. doi:10.1136/bcr-2013-008648. ISSN   1757-790X. PMC   3618781 . PMID   23456162.
  5. Onikoyi, Omobola; Adigun, Chris G.; Lui, Harvey. "Nevi of Ota and Ito" . Retrieved March 22, 2008.
  6. 1 2 Sancton, Julian (September 2011). "Daniela Ruah Officially Checks In". Esquire . New York City: Hearst Corporation . Retrieved June 9, 2016.
  7. Geronemus, Roy G. (December 1992). "Q-switched ruby laser therapy of nevus of Ota". Archives of Dermatology. 128 (12). Chicago, Illinois: American Medical Association: 1618–22. Bibcode:1992SPIE.1643..284G. doi:10.1001/archderm.1992.04530010056008. PMID   1456756.
  8. Watanabe, Shinichi; Takahashi, Hisashi (December 1, 1994). "Treatment of nevus of Ota with the Q-switched ruby laser". New England Journal of Medicine . 331 (26). Waltham, Massachusetts: Massachusetts Medical Society: 1745–50. doi: 10.1056/NEJM199412293312604 . PMID   7984195.
  9. Patil, Uddhav A.; Dhami, Lakshyajit D. (October 2008). "Overview of Lasers". Indian Journal of Plastic Surgery. 41 (Supplement) (Suppl). Mumbai, India: Medknow Publications: 101–113. doi:10.1055/S-0039-1700481. PMC   2825126 . PMID   20174534.
  10. I have a rare skin condition , retrieved 2023-08-13